SOSAFE
4.6.2024 09:01:35 CEST | Business Wire | Press release
SoSafe, Europe’s largest security awareness and human risk management vendor, has appointed seasoned HR executive Laura Ryan as Chief People Officer to support the organisation as they continue to scale operations internationally in the face of rising global cyber security threats.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240604322632/en/
Laura Ryan appointed as new Chief People Officer at largest security awareness and human risk management platform SoSafe. (Photo: Business Wire)
Laura will lead SoSafe’s people function, overseeing the development of a best-in-class team to help deliver the company’s next chapter of strategic growth. She will manage human resources, people and talent, workspace and community, and operations, acting as an engine to accelerate the company’s mission and long-term vision to strengthen digital self-defence.
With over 20 years of hands-on experience in the technology and financial services industries, Laura has actively supported the evolution of HR functions. Prior to joining SoSafe, she worked almost nine years at Dropbox, most recently as Vice President Global HR Business Partnering. Prior to this, Laura spent over five years at Google and over seven years in Financial Services in a number of HR roles, honing her HR craft.
Laura Ryan, incoming Chief People Officer at SoSafe: “Throughout my career I've been passionate about scaling organisations, helping companies achieve this by fostering innovation and creating workplaces that inspire people to do their best work. SoSafe is working in an extremely interesting market with very strong dynamics: Cybercrime is the biggest threat to organisations and SoSafe delivers a human-centric solution based on psychology. This gives the company and the team a very strong purpose and I am very excited to contribute to their mission to empower people facing digital threats.”
SoSafe is currently leading the category evolution from security awareness and training to human risk management through product innovation, accelerating its sustainable growth. Since the beginning of 2022, they have grown from 180 employees in Cologne, Germany, to 500 employees across nine locations in Europe with around 100 open positions, recently adding two additional office hubs in Dublin, Ireland, and Chemnitz, Germany.
Dr Niklas Hellemann, CEO of SoSafe: "One of the pillars of our success is the excellence of our people - we are proud to have an outstanding team to drive our ambitious plans. Laura brings a wealth of experience in fast-paced, multi-cultural organisations and has proven her ability to build and lead people divisions in high growth technology companies. I am very excited to have her join our management team and look forward to working with her to drive further growth for the business.”
Laura's appointment follows a series of senior hires to strengthen the company's expertise.:
- Megan Brown joins as Vice President of Global Partnerships, bringing more than 15 years of sales experience at LogicGate, Checkster and CareerBuilder to lead SoSafe's plans to expand its channel sales through international partnerships.
- Gina Dragulin joins as Vice President of Product Marketing to ensure that SoSafe's product innovations are brought to life and their customers get highest value. Prior to joining SoSafe, she worked for Miro, Microsoft and other tech companies while leading various marketing functions.
- Thomas Owen joins as Chief Information Security Officer, bringing with him a wealth of experience in the security industry from companies such as Grafana Labs, iloomi and Snyk.
About SoSafe
SoSafe, founded by a team of behavioural scientists and technology experts, is the largest security awareness and human risk management vendor based in Europe. SoSafe is empowering over 4700 customers worldwide to effectively mitigate cyber risk. With a unique human-centric approach grounded in behavioural science, SoSafe enhances secure behaviour across organizations, making it intuitive and second nature. The platform is designed to strengthen digital self-defence by creating robust security cultures that actively involve employees in mitigating human risks. By leveraging psychology and advanced technology and AI, it enables security professionals to effectively identify, prioritize, manage, and ultimately reduce their human risk. The SoSafe team now consists of more than 500 employees in nice locations: Cologne (headquarters), Amsterdam, Berlin, Chemnitz, Dublin, London, Paris, Lisbon, and Munich.
Website: www.sosafe-awareness.com/
LinkedIn: www.linkedin.com/company/sosafe-cyber-security/mycompany/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240604322632/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom